Biohit Oyj reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 11 million compared to EUR 9.4 million a year ago. Net income was EUR 0.6 million compared to net loss of EUR 1.5 million a year ago.

Basic earnings per share from continuing operations was EUR 0.04 compared to basic loss per share from continuing operations of EUR 0.1 a year ago. Diluted earnings per share from continuing operations was EUR 0.04 compared to diluted loss per share from continuing operations of EUR 0.1 a year ago.